Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 288 participants.
Also called NCT01851759
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 288 participants
- Sponsor
- Registry
-
NCT01851759
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01851759. Randomized; double masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2014-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction
- Condition
- Ischemic Stroke
- Intervention (Drug)
- cinepazide
- Intervention (Drug)
- placebo
- Lead sponsor
- Xijing Hospital
Record details
- Record id
cardio:ct-nct01851759- Content hash
33cb1a33f15b81cdb5ad58a1f14481101266ccbbf73564484241968a01520ef6